Valuation: G MEDPAR

Market Cap 723K 628K 585K 537K 1.01M 69.02M 1.03M 6.9M 2.71M 34.36M 2.72M 2.66M 115M P/E 2021
-1.29x
P/E 2022 -0.17x
Enterprise Value 2.52M 2.19M 2.04M 1.87M 3.54M 241M 3.59M 24.03M 9.43M 120M 9.46M 9.26M 402M EV / Sales 2021
4.92x
EV / Sales 2022 1.15x
Free-Float
-
Yield 2021 *
-
Yield 2022 -
3 months-50.00%
Current year-50.00%
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 0
0
1 year 0
Extreme 0
0.03
3 years 0
Extreme 0
0.36
5 years 0
Extreme 0
235.9
10 years 0
Extreme 0
235.9
Manager TitleAgeSince
Chief Executive Officer 75 03/10/2014
Director of Finance/CFO 46 31/07/2022
Chief Tech/Sci/R&D Officer 56 01/12/2017
Director TitleAgeSince
Director/Board Member 75 03/10/2014
Chairman 72 21/08/2014
Director/Board Member 76 24/02/2017
Date Insider Type Main position Quantity % Market Cap.
31/03/23
AWM Investment Co., Inc.
SellCompany 737,500 37.5554%
31/03/23
AWM Investment Co., Inc.
OtherCompany 1,437,500 73.2011%

Financials

2021 2022
Net sales 5.06M 4.4M 4.09M 3.76M 7.1M 483M 7.21M 48.24M 18.93M 240M 19M 18.58M 806M 4.42M 3.84M 3.58M 3.28M 6.2M 422M 6.3M 42.16M 16.54M 210M 16.6M 16.24M 704M
Net income -14.76M -12.83M -11.94M -10.96M -20.7M -1.41B -21.02M -141M -55.24M -701M -55.43M -54.21M -2.35B -13.52M -11.75M -10.94M -10.04M -18.97M -1.29B -19.26M -129M -50.61M -643M -50.78M -49.66M -2.15B
Net Debt 2.41M 2.09M 1.95M 1.79M 3.38M 230M 3.43M 22.97M 9.01M 114M 9.04M 8.84M 384M 1.8M 1.56M 1.45M 1.33M 2.52M 172M 2.56M 17.14M 6.73M 85.4M 6.75M 6.6M 286M
Logo G MEDPAR
G Medical Innovations Holdings Ltd. is a mobile health (mHealth) and e-health company. The Company is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. It also develops wireless vital signs monitoring systems.
Employees
84
Sector
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. GMVDF Stock